Kiss R, Devleeschouwer N, Paridaens R J, Danguy A, Heuson J C, Atassi G
Anticancer Res. 1986 Jul-Aug;6(4):753-9.
The B6D2F1 mouse mammary adenocarcinoma was adapted to grow in vitro as monolayer. After in vitro passaging of tumor cells, phenotypic changes occurred that were expressed in vivo. Following intraperitoneal inoculation of tumor cells, bone-forming tumors developed. These tumors consisted of undifferentiated adenocarcinoma mixed with large amount of cartilagenous and osseous tissue. The etiology of these phenotypic changes was not yet determined. However, hypothesis of the possible origin of the cartilage and bone forming tissue was formulated. The biologic characterization of the intraperitoneally bone-forming tumor was achieved and the experimental conditions to preserve and induce the reproducible sarcoma-like bone forming tumors were defined. Our data support the usefulness of this new original model for fundamental research as well as for screening of anticancer drugs.
B6D2F1小鼠乳腺腺癌经体外传代后适应单层生长。肿瘤细胞体外传代后发生了表型变化,并在体内表现出来。肿瘤细胞腹腔接种后,形成了成骨性肿瘤。这些肿瘤由未分化腺癌与大量软骨和骨组织混合而成。这些表型变化的病因尚未确定。然而,提出了软骨和骨形成组织可能起源的假说。实现了腹腔内成骨性肿瘤的生物学特性鉴定,并确定了保存和诱导可重复的肉瘤样成骨性肿瘤的实验条件。我们的数据支持这种新的原始模型在基础研究以及抗癌药物筛选中的实用性。